{
    "clinical_study": {
        "@rank": "38418", 
        "acronym": "NT-proBNP", 
        "arm_group": {
            "arm_group_label": "NT-proBNP,ejection fraction ,COPD stage.", 
            "description": "The group comprised 25 women (47%) and 28 men (53%). The mean age was 75.4 years (SD 7.9), 76.3 (SD 7.6) for men and 74.4 (SD 8.2) for women."
        }, 
        "brief_summary": {
            "textblock": "The aim of the present study was to evaluate if the analysis of NT-proBNP might be used as\n      an initial step for the diagnosis of chronic heart failure in patients with COPD in primary\n      health care, and to select patients  for a further examination by echocardiography."
        }, 
        "brief_title": "Using NT-proBNP to Detect Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary Disease", 
        "completion_date": {
            "#text": "June 2008", 
            "@type": "Actual"
        }, 
        "condition": [
            "Chronic Obstructive Pulmonary Disease", 
            "Chronic Heart Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Heart Failure", 
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with a confirmed diagnosis of COPD were examined regarding chronic heart failure.\n\n        1. An interview regarding symptoms: breathlessness, orthopnoea, night cough, nocturia,\n           walking distance.\n\n        2. Physical examination: weight and height, heart and lung auscultation, blood pressure\n           measurement after 5 minutes' rest in the sitting position and the presence of\n           peripheral oedema.\n\n        3. Electrocardiography.\n\n        4. Natriuretic peptide- NT-proBNP (Immulite 2500, Siemens Healthcare Diagnostics AB\n           Sweden).\n\n        5. Patients with the NT-proBNP level of > 1200 pg/ml were referred for echocardiography to\n           assess left ventricular function."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients aged 65 years and older with the following diagnosis codes  according to\n             International Statistical Classification of Diseases and Related Health Problems -\n             Tenth Revision:J44 (COPD) and J41, J42 (chronic bronchitis) registered during the\n             period 1 January 2008-16 April 2008 according to the electronic patient record.\n\n        Exclusion Criteria:\n\n          -  Impaired cognitive function and/or anticipated difficulties in carrying out\n             spirometry due to immobility,\n\n          -  psychiatric disorders or terminal illness."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients aged 65 years and older with a registered diagnosis of COPD."
            }
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01801722", 
            "org_study_id": "502008", 
            "secondary_id": "DN50/2008"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 28, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Olofstr\u00f6m", 
                    "country": "Sweden", 
                    "state": "Blekinge", 
                    "zip": "29332"
                }, 
                "name": "Primary health care center."
            }
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_groups": "1", 
        "official_title": "Using NT-proBNP to Detect Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary Disease.", 
        "overall_official": {
            "affiliation": "Lund University", 
            "last_name": "Elzbieta Kaszuba, PhD student", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "NT-proBNP has taken only once in each patient without follow up follow up. Three months was a period when we collected data from all participants.", 
            "measure": "Percentage of patients with elevated NT-proBNP.", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01801722"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Lund University", 
            "investigator_full_name": "Elzbieta Kaszuba", 
            "investigator_title": "PhD student", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Echocardiography was performed once in each referred patient. Three months was a period of data collection.", 
            "measure": "Percentage of patients with abnormal left ventricular function assessed by echocardiography. Association between elevated NT-proBNP and symptoms, signs and electrocardiography.", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "source": "Lund University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Lund University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2008", 
        "study_design": "Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}